Experimental manipulation of immune-mediated disease and its fitness costs for rodent malaria parasites

BMC Evolutionary Biology

Volumn 8, Issue 1, 2008, Pages

  Long, Gráinne H ^a   Chan, Brian H K ^a   Allen, Judith E ^a   Read, Andrew F ^b   Graham, Andrea L ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; GENETIC VARIABILITY; IMMUNOPATHOLOGY; MALARIA; MORTALITY; MOUSE; NONHUMAN; PARASITE VIRULENCE; PLASMODIUM CHABAUDI; ANIMAL; C57BL MOUSE; DISEASE MODEL; DRUG ANTAGONISM; EVOLUTION; GENETICS; GENOTYPE; HOST PARASITE INTERACTION; IMMUNOLOGY; INNATE IMMUNITY; PARASITOLOGY; PATHOGENICITY; PHYSIOLOGY; VIRULENCE;

PLASMODIUM CHABAUDI CHABAUDI; RODENTIA;

ANIMALS; DISEASE MODELS, ANIMAL; EVOLUTION; FEMALE; GENOTYPE; HOST-PARASITE INTERACTIONS; IMMUNITY, NATURAL; MALARIA; MICE; MICE, INBRED C57BL; PLASMODIUM CHABAUDI; RECEPTORS, INTERLEUKIN-10; VIRULENCE;

EID: 44249088146     PISSN: None     EISSN: 14712148     Source Type: Journal    
DOI: 10.1186/1471-2148-8-128     Document Type: Article

References (67)

1. Adaptive Dynamics of Infectious Diseases: In Pursuit of Virulence Management. U Dieckmann JAJ Metz MW Sabelis K Sigmund, Cambridge University Press First 2002
2. Coevolution of hosts and parasites. RM Anderson RM May, Parasitology 1982 85 Pt 2 411 426 6755367
3. The evolution of parasitic diseases. D Ebert EA Herre, Parasitol Today 1996 12 3 96 101 10.1016/0169-4758(96)80668-5 15275238
4. Host-parasite relations, vectors and the evolution of disease severity. PW Ewald, Annual Review of Ecology and Systematics 1983 14 465 485 10.1146/annurev.es.14.110183.002341
5. Models of parasite virulence. SA Frank, Quarterly Review of Biology 1996 71 1 37 78 10.1086/419267 8919665
6. The evolution of virulence. AF Read, Trends in Microbiology 1994 2 3 73 76 10.1016/0966-842X(94)90537-1 8156274
7. Evolutionary causes and consequences of immunopathology. AL Graham JE Allen AF Read, Annual Review of Ecology, Evolution, & Systematics 2005 36 337 397
8. Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria. D Dodoo FM Omer J Todd BD Akanmori KA Koram EM Riley, Journal of Infectious Disease 2002 185 7 971 979 10.1086/339408 11920322
9. The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology. K Artavanis-Tsakonas JE Tongren EM Riley, Clinical and Experimental Immunology 2003 133 2 145 152 10.1046/j.1365-2249. 2003.02174.x
10. Pathogenesis of malaria and clinically similar conditions. IA Clark LM Alleva AC Mills WB Cowden, Clinical Microbiology Reviews 2004 17 3 509 539 15258091 10.1128/CMR.17.3.509-539.2004
11. Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen. TR Jones DL Narum AS Gozalo J Aguiar SR Fuhrmann H Liang JD Haynes JK Moch C Lucas T Luu, Journal of Infectious Disease 2001 183 2 303 312 11110648 10.1086/317933
12. Blood and bone marrow changes in malaria. SN Wickramasinghe SH Abdalla, Baillieres Best Practice and Research Clinical Haematology 2000 13 2 277 299 10942626 10.1053/beha.1999.0072
13. Up-regulation of Th1-type responses in mucosal leishmaniasis patients. O Bacellar H Lessa A Schriefer P Machado A Ribeiro de Jesus WO Dutra KJ Gollob EM Carvalho, Infection and Immunity 2002 70 12 6734 6740 10.1128/IAI.70.12.6734- 6740.2002 12438348
14. Activated inflammatory T cells correlate with lesion size in human cutaneous leishmaniasis. LR Antonelli WO Dutra RP Almeida O Bacellar EM Carvalho KJ Gollob, Immunology Letters 2005 101 2 226 230 10.1016/j.imlet.2005.06.004 16083969
15. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. MD de Jong CP Simmons TT Thanh VM Hien GJ Smith TN Chau DM Hoang NV Chau TH Khanh VC Dong, Nature Medicine 2006 12 10 1203 1207 10.1038/nm1477 16964257
16. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. D Kobasa SM Jones K Shinya JC Kash J Copps H Ebihara Y Hatta JH Kim P Halfmann M Hatta, Nature 2007 445 7125 319 323 10.1038/nature05495 17230189
17. Immunopathology of schistosomiasis mansoni in mice and men. AW Cheever KF Hoffmann TA Wynn, Immunology Today 2000 21 9 465 466 10.1016/S0167-5699(00) 01626-1 10953099
18. Virulence and transmissibility of pathogens: what is the relationship? M Lipsitch ER Moxon, Trends in Microbiology 1997 5 1 31 37 10.1016/S0966-842X(97) 81772-6 9025233
19. Challenging the trade-off model for the evolution of virulence: is virulence management feasible? D Ebert JJ Bull, Trends in Microbiology 2003 11 1 15 20 10.1016/S0966-842X(02)00003-3 12526850
20. Emergence of a Convex Trade-Off between Transmission and Virulence. S Alizon M van Baalen, The American Naturalist 2005 165 66 6 15937740
21. Evolution of parasite virulence when host responses cause disease. T Day AL Graham AF Read, P Roy Soc Lond B Bio 2007 274 2685 2692 10.1098/rspb.2007. 0809 17711836
22. Virulence in malaria: an evolutionary viewpoint. MJ Mackinnon AF Read, Philos Trans R Soc Lond B Biol Sci 2004 359 1446 965 986 15306410 10.1098/rstb.2003.1414
23. Innate immunity to malaria. MM Stevenson EM Riley, Nature Reviews Immunology 2004 4 3 169 180 10.1038/nri1311 15039754
24. Dendritic cells, pro-inflammatory responses, and antigen presentation in a rodent malaria infection. J Langhorne FR Albano M Hensmann L Sanni E Cadman C Voisine AM Sponaas, Immunological Reviews 2004 201 35 47 10.1111/j.0105-2896. 2004.00182.x 15361231
25. T(H)1 cells control themselves by producing interleukin-10. A O'Garra P Vieira, Nature Reviews Immunology 2007 7 6 425 428 10.1038/nri2097 17525751
26. Interleukin-10 modulates susceptibility in experimental cerebral malaria. S Kossodo C Monso P Juillard T Velu M Goldman GE Grau, Immunology 1997 91 4 536 540 9378491 10.1046/j.1365-2567.1997.00290.x
27. Cerebral edema and cerebral hemorrhages in interleukin-10-deficient mice infected with Plasmodium chabaudi. LA Sanni W Jarra C Li J Langhorne, Infection and Immunity 2004 72 5 3054 3058 10.1128/IAI.72.5.3054-3058.2004 15102820
28. Plasmodium chabaudi chabaudi: differential susceptibility of gene-targeted mice deficient in IL-10 to an erythrocytic-stage infection. A Linke R Kuhn W Muller N Honarvar C Li J Langhorne, Experimental Parasitology 1996 84 2 253 263 10.1006/expr.1996.0111 8932775
29. Pathology of Plasmodium chabaudi chabaudi infection and mortality in interleukin-10-deficient mice are ameliorated by anti-tumor necrosis factor alpha and exacerbated by anti-transforming growth factor beta antibodies. C Li LA Sanni F Omer E Riley J Langhorne, Infection and Immunity 2003 71 9 4850 4856 10.1128/IAI.71.9.4850-4856.2003 12933825
30. A defect in interleukin-10 leads to enhanced malarial disease in Plasmodium chabaudi chabaudi infection in mice. C Li I Corraliza J Langhorne, Infection and Immunity 1999 67 9 4435 4442 10456884
31. Differential induction of TGF-beta regulates proinflammatory cytokine production and determines the outcome of lethal and nonlethal Plasmodium yoelii infections. FM Omer JB de Souza EM Riley, J Immunol 2003 171 10 5430 5436 14607947
32. Genetic relationships between parasite virulence and transmission in the rodent malaria Plasmodium chabaudi. MJ Mackinnon AF Read, Evolution International Journal of Organic Evolution 1999 53 689 703
33. Adaptive changes in Plasmodium transmission strategies following chloroquine chemotherapy. AG Buckling LH Taylor JM Carlton AF Read, P Roy Soc Lond B Bio 1997 264 1381 553 559 9149425 10.1098/rspb.1997.0079
34. Determinants of transmission success of individual clones from mixed-clone infections of the rodent malaria parasite, Plasmodium chabaudi. LH Taylor AF Read, Int J Parasitol 1998 28 5 719 725 10.1016/S0020-7519(98)00032-0 9650051
35. Interleukin-10 and the interleukin-10 receptor. KW Moore R de Waal Malefyt RL Coffman A O'Garra, Annual Review of Immunology 2001 19 683 765 10.1146/annurev.immunol.19.1.683 11244051
36. A hallmark of balancing selection is present at the promoter region of interleukin 10. JN Wilson K Rockett B Keating M Jallow M Pinder F Sisay-Joof M Newport D Kwiatkowski, Genes and Immunity 2006 7 680 683 10.1038/sj.gene.6364336 16943796
37. IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. CA Hunter LA Ellis-Neyes T Slifer S Kanaly G Grunig M Fort D Rennick FG Araujo, J Immunol 1997 158 7 3311 3316 9120288
38. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. RT Gazzinelli M Wysocka S Hieny T Scharton-Kersten A Cheever R Kuhn W Muller G Trinchieri A Sher, J Immunol 1996 157 2 798 805 8752931
39. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. MC Kullberg JM Ward PL Gorelick P Caspar S Hieny A Cheever D Jankovic A Sher, Infection and Immunity 1998 66 11 5157 5166 9784517
40. Within-Host Population Dynamics and the Evolution and Maintenance of Microparasite Virulence. R Antia BR Levin RM May, The American Naturalist 1994 144 3 457 472 10.1086/285686
41. Mathematical models of parasite responses to host immune defences. R Antia M Lipsitch, Parasitology 1997 115 Suppl S155 167 10.1017/S003118209700200X 9571700
42. Imperfect vaccines and the evolution of pathogen virulence. S Gandon MJ Mackinnon S Nee AF Read, Nature 2001 414 6865 751 756 10.1038/414751a 11742400
43. Virulence evolution in response to vaccination: the case of malaria. MJ Mackinnon S Gandon AF Read, Vaccine 2007
44. Evolution in Health and Disease. AF Read MJ Mackinnon, Chapter 12: Pathogen evolution in a vaccinated world Oxford University Press, Stearns SC, Koella JC, 2
45. The effects of host immunity on virulence-transmissibility relationships in the rodent malaria parasite Plasmodium chabaudi. MJ Mackinnon AF Read, Parasitology 2003 126 Pt 2 103 112 10.1017/S003118200200272X 12636347
46. Immunity Promotes Virulence Evolution in a Malaria Model. MJ Mackinnon AF Read, PLoS Biology 2004 2 9 E230 15221031 10.1371/journal.pbio.0020230
47. Myxomatosis. F Fenner RN Ratcliffe, Cambridge University Press 1965
48. Biological Control of Vertebrate Pests. F Fenner B Fantini, The History of Myxomatosis-An Experiment in Evolution CAB International Publishing, Wallingford, UK 1999
49. Coevolution of host and virus: the pathogenesis of virulent and attenuated strains of myxoma virus in resistant and susceptible European rabbits. SM Best PJ Kerr, Virology 2000 267 1 36 48 10.1006/viro.1999.0104 10648181
50. Virulence and pathogenesis of the MSW and MSD strains of Californian myxoma virus in European rabbits with genetic resistance to myxomatosis compared to rabbits with no genetic resistance. L Silvers B Inglis A Labudovic PA Janssens BH van Leeuwen PJ Kerr, Virology 2006 348 1 72 83 10.1016/j.virol.2005. 12.007 16442580
51. Top-down or bottom-up regulation of intra-host blood-stage malaria: do malaria parasites most resemble the dynamics of prey or predator? DT Haydon L Matthews R Timms N Colegrave, Proc Biol Sci 2003 270 1512 289 298 12614579 10.1098/rspb.2002.2203
52. Parasite genetic diversity does not influence TNF-mediated effects on the virulence of primary rodent malaria infections. GH Long BH Chan JE Allen AF Read AL Graham, Parasitology 2006 133 Pt 6 673 684 10.1017/S003118200600117X 16978451
53. Hijacking and exploitation of IL-10 by intracellular pathogens. S Redpath P Ghazal NRJ Gascoigne, Trends in Microbiology 2001 9 86 92 10.1016/S0966-842X(00)01919-3 11173248
54. Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. DH Hsu, Science 1990 250 830 832 10.1126/science.2173142 2173142
55. Human cytomegalovirus harbours its own unique IL-10 homologue (cmvIL-10). SV Kotenko S Saccani LS Izotova OV Mirochnitchenko S Pestka, Proceedings of the National Academy of Sciences USA 2000 97 1695 1700 10677520 10.1073/pnas.97.4.1695
56. Resolution of a chronic viral infection after interleukin-10 receptor blockade. M Ejrnaes, Journal of Experimental Medicine 2006 203 2461 2472 17030951 10.1084/jem.20061462
57. Interleukin-10 determines viral clearance or persistence in vivo. DG Brooks, Nature Medicine 2006 12 1301 1309 10.1038/nm1492 17041596
58. Blockade of TNF receptor 1 reduces disease severity but increases parasite transmission during Plasmodium chabaudi chabaudi infection. GH Long BHK Chan JE Allen AF Read AL Graham, Int J Parasitol Corrected Proof
59. Gametocytes. R Carter PM Graves, Malaria: Principles and Practise of Malariology Churchill Livingstone, Wensdorfer W, McGregor I, 1988 1 253 306
60. Induction of sexual differentiation in malaria. B Mons, Parasitology Today 1985 1 3 87 89 10.1016/0169-4758(85)90050-X 15275604
61. Regulation of infectivity of Plasmodium to the mosquito vector. RE Sinden GA Butcher O Billker SL Fleck, Advances in Parasitology 1996 38 53 117 8701799
62. The effect of chloroquine treatment on the infectivity of Plasmodium chabaudi gametocytes. AGJ Buckling AF Read, Int J Parasitol 1999 29 4 619 626 10.1016/S0020-7519(98)00230-6 10428639
63. Does helminth elimination promote or prevent malaria? S Specht A Hoerauf, Lancet 2007 369 9560 446 447 10.1016/S0140-6736(07)60210-4 17292747
64. Co-infection of helminths and malaria: modulation of the immune responses to malaria. FC Hartgers M Yazdanbakhsh, Parasite Immunology 2006 28 10 497 506 10.1111/j.1365-3024.2006.00901.x 16965285
65. [Description Of Plasmodium Chabaudi N. Sp., Parasite Of African Rodents.]. I Landau, Comptes Rendus Hebdomadaires des Seances de l Academie des Sciences 1965 260 3758 3761 14339659
66. Genetic recombination in malaria parasites. D Walliker R Carter S Morgan, Nature 1971 232 5312 561 562 10.1038/232561a0 4937500
67. Murine malaria: genetic control of resistance to Plasmodium chabaudi. MM Stevenson JJ Lyanga E Skamene, Infection and Immunity 1982 38 1 80 88 7141699